Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$106.50 USD
-1.31 (-1.22%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $106.58 +0.08 (0.08%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum C VGM
Average Brokerage Rating
Current ABR | 2.57 |
ABR (Last week) | 2.57 |
# of Recs in ABR | 28 |
Average Target Price | $124.25 |
LT Growth Rate | 6.80% |
Industry | Medical - Products |
Industry Rank by ABR | 70 of 253 |
Current Quarter EPS Est: | 1.77 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 7 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 17 | 17 | 16 | 16 | 16 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 2 | 2 | 2 | 2 | 2 |
ABR | 2.57 | 2.57 | 2.56 | 2.56 | 2.56 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/10/2024 | Not Identified | Not Identified | Not Available | Hold |
9/6/2024 | Cowen & Co. | Joshua T Jennings | Hold | Hold |
9/5/2024 | Not Identified | Not Identified | Hold | Hold |
9/5/2024 | Truist Securities | Richard Newitter | Hold | Hold |
8/20/2024 | Canaccord Genuity | William J Plovanic | Hold | Hold |
8/8/2024 | Wells Fargo Securities | Lawrence H Biegelsen | Hold | Hold |
8/8/2024 | Robert W. Baird & Co. | Jeffrey D Johnson | Strong Buy | Strong Buy |
8/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/8/2024 | UBS | Danielle Antalffy | Strong Sell | Strong Sell |
8/8/2024 | Raymond James | Jayson T Bedford | Moderate Buy | Moderate Buy |
8/8/2024 | Evercore Partners | Vijay Kumar | Hold | Hold |
8/8/2024 | Needham & Company | Michael Matson | Hold | Hold |
8/8/2024 | JMP Securities | David L Turkaly | Strong Buy | Strong Buy |
8/7/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/7/2024 | BTIG | Ryan Zimmerman | Strong Buy | Strong Buy |
7/16/2024 | Roth Capital Partners | Jason Wittes | Hold | Hold |
7/10/2024 | Not Identified | Not Identified | Hold | Hold |
7/1/2024 | Piper Sandler | Matthew O'Brien | Strong Buy | Hold |
5/31/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
5/30/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
5/30/2024 | Goldman Sachs | David H Roman | Not Available | Hold |
5/21/2024 | Argus Research Corp. | David A Toung | Not Available | Strong Buy |
5/2/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/2/2024 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.